# Lesogaberan in Chinese Patients With Refractory Reflux Symptoms

> **NCT02818309** · PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Lesogaberan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02818309
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2016-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818309, "Lesogaberan in Chinese Patients With Refractory Reflux Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02818309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*